Identification of GP100-derived, melanoma-specific cytotoxic T- lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells

International Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 518-524

  Kawashtma, Ichiro ^a,b   Tsai, Van ^a   Southwood, Scott ^a   Takesako, Kazutoh ^b   Celis, Esteban ^c,d   Sette, Alessandro ^a  

^a Epimmune   (United States)

^b TAKARA SHUZO CO LTD   (Japan)

^c MAYO GRADUATE SCHOOL   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ARTICLE; CELL SPECIFICITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOMA; PRIORITY JOURNAL;

CELL LINE; CELLS, CULTURED; CROSS REACTIONS; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HLA-A3 ANTIGEN; HUMANS; IMMUNIZATION; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031755442     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981109)78:4<518::AID-IJC20>3.0.CO;2-0     Document Type: Article

References (31)

1. BAKKER, A.B., SCHREURS, M.W., DE BOER, A.J., KAWAKAMI, Y., ROSENBERG, S.A., ADEMA, G.J. and FIGDOR, C.G., Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. exp. Med., 179, 1005-1009 (1994).
2. BERKE, G., The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Ann. Rev. Immunol., 12, 735-773 (1994).
3. BRICHARD, V., VAN PEL, A., WÖLFEL, T., WOLFEL, C., DE PLAEN, E., LETHE, B., COULIE, P. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489-495 (1993).
4. 17-25) peptide in HLA-A3.1 melanoma patients. Europ. J. Immunol., 28, 1143-1154 (1998).
5. COULIE, P.G., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHINDER, J., TRAVERSARI, C., MATTEL S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.P., RENAULD, J.C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-12 (1994).
6. COX, A.L., SKIPPER, J., CHEN, Y., HENDERSON, R.A., DARROW, T.L., SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINGLUFF, C.L., JR., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
7. JAEGER, E., BERNHARD, H., ROMERO, P., RINGHOFFER, M., ARAND, M., KARBACH, J., ILSEMANN, C., HAGEDORN, M. and KNUTH, A., Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for rumor vaccines with melanoma-associated antigens. Int. J. Cancer, 66, 162-169 (1996).
8. JAGER, E., RINGHOFFER, M., DIENES, H.P., ARAND, M., KARBACH, J., JÄGER, D., ILSEMANN, C., HAGEDORN, M., OESCH, F. and KNUTH, A., Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer, 67, 54-62 (1996).
9. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T. and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 3515-3519 (1994).
10. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., SAKAGUCHI, K., APPELLA, E., YANNELLI, J.R., ADEMA, G.J., MIKI, T. and ROSENBERG, S.A., Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat. Acad. Sci. (Wash.), 91, 6458-6462 (1994).
11. KAWAKAMI, Y., ELIYAHU, S., JENNINGS, C., SAKAGUCHI, K., KANG, X., SOUTHWOOD, S., ROBBINS, P.F., SETTE, A., APPELLA, E. and ROSENBERG, S.A., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol., 154, 3961-3968 (1995).
12. + CTLs from naive precursors. J. Immunol., 153, 996-1003 (1994).
13. OKADA, C.Y. and RECHSTEINER, M., Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell, 29, 33-41 (1982).
14. RAMMENSEE, H.G., FALK, K. and ROTZSCHKE, O., Peptides naturally presented by MHC class I molecules. Ann. Rev. Immunol., 11, 213-244 (1993).
15. RIDDELL, S.R., ELLIOTT, M., LEWINSOHN, D.A., GILBERT, M.J., WILSON, L., MANLEY, S.A., LUPTON, S.D., OVERELL, R.W., REYNOLDS, T.C., COREY, L. and GREENBERG, P.D., T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature (Med.), 2, 216-223 (1996).
16. ROMANI, N., GRUNER, S., BRANG, D., KAMPGEN, E., LENZ, A., TROCKEN-BACHER, B., KONWALINKA, G., FRITSCH, P.O., STEINMAN, R.M. and SCHULER, G., Proliferating dendritic cell progenitors in human blood. J. exp. Med., 180, 83-93 (1994).
17. ROSENBERG, S.A. and 15 OTHERS, Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature (Med.), 4, 321-327 (1998).
18. SALLUSTO, F. and LANZAVECCHIA, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. exp. Med., 179, 1109-1118 (1994).
19. SIDNEY, J., GREY, H.M., SOUTHWOOD, S., CELIS, E., WENTWORTH, P.A., DEL GUERCIO, M.F., KUBO, R.T., CHESNUT, R.W. and SETTE, A., Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum. Immunol., 45, 79-93 (1996).
20. SKIPPER, J.C., KITTLESEN, D.J., HENDRICKSON, R.C., DEACON, D.D., HARTHUN, N.L., WAGNER, S.N., HUNT, D.F., ENGELHARD, V.H. and SLINGLUFF, C.L., JR., Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. J. Immunol., 157, 5027-5033 (1996).
21. STORKUS, W.J., ZEH, HJ.D., MAEURER, M.J., SALTER, R.D. and LOTZE, M.T., Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J. Immunol. 151, 3719-3727 (1993).
22. THRELKELD, S.C., WENTWORTH, P.A., KALAMS, S.A., WILKES, B.M., RUHL, D.J., KEOGH, E., SIDNEY, J., SOUTHWOOD, S., WALKER, B.D. and SETTE, A., Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J. Immunol., 159, 1648-1657 (1997).
23. TSAI, V., KAWASHIMA, I., KEOGH, E., DALY, K., SETTE, A. and CELIS, E., In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells. Crit. Rev. Immunol., 18, 65-75 (1998).
24. TSAI, V., SOUTHWOOD, S., SIDNEY, J., SAKAGUCHI, K., KAWAKAMI, Y., APPELLA, E., SETTE, A. and CELIS, E., Identification of subdominant CTL epitopes of the gp100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol., 158, 1796-1802 (1997).
25. VAN DEN EYNDE, B.J. and BOON, T., Tumor antigens recognized by T lymphocytes. Int. J. clin. Lab. Res., 27, 81-86 (1997).
26. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
27. WANG, R.F., APPELLA, E., KAWAKAMI, Y., KANG, X. and ROSENBERG, S.A., Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. exp. Med., 184, 2207-2216 (1996).
28. WANG, R.F., ROBBINS, P.F., KAWAKAMI, Y., KANG, X.Q. and ROSENBERG, S.A., Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. exp. Med., 181, 799-804 (1995).
29. WENTWORTH, P.A. and 15 OTHERS, In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol., 32, 603-612 (1995).
30. YORK, I.A. and ROCK, K.L., Antigen processing and presentation by the class I major histocompatibility complex. Ann. Rev. Immunol., 14, 369-396 (1996).
31. ZINKERNAGEL, R.M. and DOHERTY, P.C., The discovery of MHC restriction. Immunol. Today, 18, 14-17 (1997).